Skip to main content

Animations

MJFF Publications

1501 - 1510 of 8823 Results
Title
Year
  • Year
  • 2025
  • 2025
  • 2024
  • 2025
  • 2023
  • 2024
  • 2024
  • 2023
  • 2023
  • 2023
  • Summary Details
    OPEN
    Title: Mitochondrial complex I deficiency occurs in skeletal muscle of a subgroup of individuals with Parkinson’s disease
    Journal Name: Communications Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s43856-025-00817-7
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Cryo-TEM structure of β-glucocerebrosidase in complex with its transporter LIMP-2
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-025-58340-1
    Citation Count: 3
  • Summary Details
    OPEN
    Title: A data-driven model of disability progression in progressive multiple sclerosis
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcae434
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Exploring the early drivers of pain in Parkinson’s disease
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41598-025-90678-w
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Development of a highly potent and selective degrader of LRRK2
    Journal Name: Bioorganic & Medicinal Chemistry Letters
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.bmcl.2023.129449
    Citation Count: 16
  • Summary Details
    OPEN
    Title: N-acetylation of α-synuclein enhances synaptic vesicle clustering mediated by α-synuclein and lysophosphatidylcholine
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7554/elife.97228
    Citation Count: 8
  • Summary Details
    OPEN
    Title: The Amplification of Alpha‐Synuclein Amyloid Fibrils is Suppressed under Fully Quiescent Conditions
    Journal Name: Angewandte Chemie International Edition
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/anie.202419173
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Externally validated deep learning model to identify prodromal Parkinson’s disease from electrocardiogram
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-023-38782-7
    Citation Count: 17
  • Summary Details
    OPEN
    Title: LRRK2 suppresses lysosome degradative activity in macrophages and microglia through MiT-TFE transcription factor inhibition
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1073/pnas.2303789120
    Citation Count: 67
  • Summary Details
    OPEN
    Title: FBXL4 suppresses mitophagy by restricting the accumulation of NIX and BNIP3 mitophagy receptors
    Journal Name: The EMBO Journal
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.15252/embj.2022112767
    Citation Count: 71
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.